These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1019836)

  • 1. BCG immunotherapy: effects of dose and route of administration in mice bearing established tumors.
    Codish SD; Monaco AP
    Surg Forum; 1976; 27(62):150-2. PubMed ID: 1019836
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful immunotherapy with BCG as an adjunct to surgical resection for murine fibrosarcoma.
    Sonis ST; Stelos P; Wilson RE
    Surg Forum; 1975; 26():133-5. PubMed ID: 1216088
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 5. [An attempt to control the growth of syngeneic experimental tumors in inbred mice using Listeria factor Ei, BCG vaccine and a combination of both].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8):230-7. PubMed ID: 2617123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL; Rios A
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.
    Sparks FC; Breeding JH
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
    Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M; Saito M; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuraminidase treated cells and their role in cancer immunotherapy.
    Simmons RL; Rios A
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):223-8. PubMed ID: 4611534
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of Listeria factor Ei, BCG vaccine and a combination of both on the growth of experimental syngeneic tumors in inbred mice].
    Zák M; Mára M; Jirkovský J
    Sb Lek; 1989 Sep; 91(8-9):230-7. PubMed ID: 2562579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immuno-therapy of methyl cholanthrene induced and spontaneous tumors in mice by use of tumor vaccine, neuraminidase and BCG.
    Gautam S; Aikat BK
    Indian J Med Res; 1976 Mar; 64(3):472-81. PubMed ID: 965048
    [No Abstract]   [Full Text] [Related]  

  • 13. Splenic influence on beta-hemolytic streptococci immunotherapy of a chemically induced murine fibrosarcoma.
    Yamagishi H; Pellis NR; Kahan BD
    Surg Forum; 1979; 30():125-7. PubMed ID: 395675
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined use of BCG and neuraminidase in experimental tumor immunotherapy.
    Simmons RL; Rios A
    Surg Forum; 1971; 22():99-101. PubMed ID: 4941334
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental study on local immunochemotherapy].
    Kasuga M; Sakita M; Yamane T; Torii T; Imai H; Kageyama N; Fujita Y; Majima S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2113-21. PubMed ID: 6820889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus Calmette-Guérin cell wall immunotherapy of intramuscular and metastatic Morris rat hepatomas.
    Wepsic HT; Tracey RS; Sell S; Harris S; Ribi E; Morris H
    Cancer Res; 1978 May; 38(5):1217-22. PubMed ID: 205358
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental cancer immunotherapy using a neuraminidase-treated non-viable frozen tumor vaccine.
    Rios A; Simmons RL
    Surgery; 1974 Apr; 75(4):503-7. PubMed ID: 4840798
    [No Abstract]   [Full Text] [Related]  

  • 20. Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.
    Milas L; Hunter N; Withers HR
    Cancer Res; 1974 Mar; 34(3):613-20. PubMed ID: 4590922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.